Quiz: Hormone Therapy in Menopausal Women

Author: Amy E. Beddoe, PhD, MS, BSN, RN; Reviewer: JoAnn E. Manson, MD, DrPH


July 18, 2014

Over the past 2 decades, contradictory results from hormone therapy (HT) research have led to confusion over the benefits and risks for menopausal women. Early observational studies showed the benefits of HT in alleviating menopausal symptoms and even suggested some cardiac benefit. But subsequent large-scale, randomized controlled trials (RCTs), such as the Women's Health Initiative (WHI) of 2002,[1] reported increased health risks to women on HT, whether taking an estrogen-only or combined estrogen-progestogen formulation. Absolute risks were small in the younger women, however. Other meta-analyses and RCTs reported varying degrees and types of risks.[2]

To help provide guidance to clinicians, the North American Menopause Society (NAMS) issued a position statement in 2012 that integrates additional significant findings into their recommendations.[3] How does your understanding accord with these guidelines? Take our quiz to find out.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.